Welcome to our dedicated page for EUDA Health Holdings SEC filings (Ticker: EUDAW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
EUDA Health Holdings Limited filings document a foreign private issuer with ordinary shares and listed warrants, using Form 6-K reports to disclose material events, Nasdaq listing-compliance notices, capital actions, securities purchase agreements and warrant matters. The filings include disclosures on a board-approved reverse stock split, adjustments to warrant terms, a registered ordinary-share offering under a Form F-3 shelf registration statement, and the repurchase and cancellation of a warrant.
EUDA's regulatory reports also describe its healthcare activities in Asia, including a non-exclusive arrangement to market selected Shenzhen Inno immunotherapies to customers in Malaysia through CK Health Plus Sdn Bhd, with treatments conducted in China.